Amlodipine contraindications: Difference between revisions
Jump to navigation
Jump to search
m Changed protection level for "Amlodipine contraindications" ([Edit=Allow only autoconfirmed users] (expires 21:31, 26 March 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 21:31, 26 March 2014 (UTC))) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{CMG}} | __NOTOC__ | ||
{{Amlodipine}} | |||
{{CMG}}; {{AE}} {{AK}} | |||
==Contraindication== | |||
Amlodipine besylate tablets are contraindicated in patients with known sensitivity to Amlodipine.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NORVASC (AMLODIPINE BESYLATE) TABLET [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44e5ad27-e062-461a-bdf4-192d852fbc49#nlm42230-3 | publisher = | date = | accessdate = 6 March 2014 }}</ref> | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 21:46, 12 March 2014
| Amlodipine |
|---|
| NORVASC®, AMLODIPINE®, AMLODIPINE BESYLATE® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Amlodipine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Contraindication
Amlodipine besylate tablets are contraindicated in patients with known sensitivity to Amlodipine.[1]
References
- ↑ "NORVASC (AMLODIPINE BESYLATE) TABLET [CARDINAL HEALTH]". Retrieved 6 March 2014.